Yi Liu‐Chittenden

3.1k citations
14 papers · 2.5k indexed · 2 hit papers · h-index 12
Topics
Cancer, Hypoxia, and Metabolism (3 papers)Hippo pathway signaling and YAP/TAZ (3 papers)Ubiquitin and proteasome pathways (3 papers)
Partner nations
United StatesChinaIsrael

In The Last Decade

Yi Liu‐Chittenden

14 papers receiving 2.5k citations

Hit Papers

Genetic and pharmacological disruption of the TEAD–YAP co...2008202620142020201220082505007501000

Peers

Yi Liu‐Chittenden
Comparison fields: 5 of 96
  • Cell Biology 1.7k
  • Molecular Biology 1.3k
  • Virology 323
  • Infectious Diseases 249
  • Oncology 226
Replace Jean Michel Heard with:
Jean Michel Heard France
Laurence Covassin United States
Kristi G. Bache Norway
Sabine Kupzig United Kingdom
Emilie H. Mules United States
Uma Sankar United States
Li‐Ru You Taiwan
Qiaoran Xi China
Leslie Petch United States
Mark Stoneley United Kingdom
Yi Liu‐Chittenden relative to Jean Michel Heard France Jean Michel Heard's profile →
Citations per field
00.5×7.9×
Jean Michel Heard · 1×
Citations per year

Countries citing papers authored by Yi Liu‐Chittenden

Since Specialization
Citations

This map shows the geographic impact of Yi Liu‐Chittenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Liu‐Chittenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Liu‐Chittenden more than expected).

Fields of papers citing papers by Yi Liu‐Chittenden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Liu‐Chittenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Liu‐Chittenden. The network helps show where Yi Liu‐Chittenden may publish in the future.

Co-authorship network of co-authors of Yi Liu‐Chittenden

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Liu‐Chittenden. A scholar is included among the top collaborators of Yi Liu‐Chittenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Liu‐Chittenden. Yi Liu‐Chittenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 6
2 4
3 13
4 44
5 17
6 25
7 24
8 32
9 40
10 231
11
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPbreakdown →
1125
12
The TEAD/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathwaybreakdown →
544
13 48
14 335

About Yi Liu‐Chittenden

Yi Liu‐Chittenden is a scholar working on Cancer Research, Biochemistry and Virology, having authored 14 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cell Biology (1.7k citations), Virology (323 citations) and Molecular Biology (1.3k citations). Yi Liu‐Chittenden has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Duojia Pan, Bo Huang, Qian Chen, Joong Sup Shim, Robert A. Anders, Jun O. Liu, Yonggang Zheng, Shian Wu, Jixin Dong and Jianzhong Yu. Their work appears in journals such as Nucleic Acids Research, Journal of Neuroscience and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026